ARTH Arch Therapeutics, Inc. - 10-K/A
Filed Mar 1, 2024 for fiscal period ending Sep 30, 2023. See issuer overview · financials · original on SEC.gov ↗
Accession
0001437749-24-006301Signal
Neutralfull-docYoY shift: Unscored
Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.
Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.
Per-snippet highlights
Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.
No section text extracted for this filing. The 10-K may use a non-standard template that the parser doesn't recognize - the original doc is still linked in the Stats tab.
No section text extracted for this filing. The 10-K may use a non-standard template that the parser doesn't recognize - the original doc is still linked in the Stats tab.
Material contracts, certifications & more
3 exhibits filed with this 10-K
- Ticker
- ARTH
- CIK
0001537561- Form Type
- 10-K/A
- Accession Number
0001437749-24-006301- Filed
- Mar 1, 2024
- Period
- Sep 30, 2023 (Q3 23)
- Industry
- Surgical & Medical Instruments & Apparatus
External resources
Permalink
https://insiderdelta.com/issuers/ARTH/10-k/0001437749-24-006301